Literature DB >> 16406325

Dystroglycan is required for proper retinal layering.

Andrea Lunardi1, Federico Cremisi, Luciana Dente.   

Abstract

Dystroglycan (DG) is a transmembrane receptor linking the extracellular matrix to the internal cytoskeleton. Its structural function has been mainly characterized in muscle fibers, but DG plays signaling and developmental roles also in different tissues and cell types. We have investigated the effects of dystroglycan depletion during eye development of Xenopus laevis. We have injected a specific morpholino (Mo) antisense oligonucleotide in the animal pole of one dorsal blastomere of embryos at four cells stage. Mo-mediated loss of DG function caused disruption of the basal lamina layers, increased apoptosis and reduction of the expression domains of specific retinal markers, at early stages. Later in development, morphants displayed unilateral ocular malformations, such as microphtalmia and retinal delayering with photoreceptors and ganglion cells scattered throughout the retina or aggregated in rosette-like structures. These results recall the phenotypes observed in specific human diseases and suggest that DG presence is crucial at early stages for the organization of retinal architecture.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406325     DOI: 10.1016/j.ydbio.2005.11.044

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  12 in total

1.  Laminin β2 Chain Regulates Retinal Progenitor Cell Mitotic Spindle Orientation via Dystroglycan.

Authors:  Dmitri Serjanov; Galina Bachay; Dale D Hunter; William J Brunken
Journal:  J Neurosci       Date:  2018-05-31       Impact factor: 6.167

2.  Defects in eye development in transgenic mice overexpressing the heparan sulfate proteoglycan agrin.

Authors:  Peter G Fuerst; Steven M Rauch; Robert W Burgess
Journal:  Dev Biol       Date:  2006-12-02       Impact factor: 3.582

3.  Laminin deficits induce alterations in the development of dopaminergic neurons in the mouse retina.

Authors:  Viktória Dénes; Paul Witkovsky; Manuel Koch; Dale D Hunter; Germán Pinzón-Duarte; William J Brunken
Journal:  Vis Neurosci       Date:  2007-08-22       Impact factor: 3.241

4.  Defective formation of the inner limiting membrane in laminin beta2- and gamma3-null mice produces retinal dysplasia.

Authors:  Germán Pinzón-Duarte; Gerard Daly; Yong N Li; Manuel Koch; William J Brunken
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-11       Impact factor: 4.799

5.  Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophy.

Authors:  Huaiyu Hu; Joseph Candiello; Peng Zhang; Sherry L Ball; David A Cameron; Willi Halfter
Journal:  Mol Vis       Date:  2010-07-28       Impact factor: 2.367

6.  Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina.

Authors:  Devid Damiani; John J Alexander; Jason R O'Rourke; Mike McManus; Ashutosh P Jadhav; Constance L Cepko; William W Hauswirth; Brian D Harfe; Enrica Strettoi
Journal:  J Neurosci       Date:  2008-05-07       Impact factor: 6.167

7.  Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development.

Authors:  Reena Clements; Rolf Turk; Kevin P Campbell; Kevin M Wright
Journal:  J Neurosci       Date:  2017-07-31       Impact factor: 6.167

8.  Dystroglycan is involved in skin morphogenesis downstream of the Notch signaling pathway.

Authors:  Cathy Sirour; Magdalena Hidalgo; Valérie Bello; Nicolas Buisson; Thierry Darribère; Nicole Moreau
Journal:  Mol Biol Cell       Date:  2011-06-16       Impact factor: 4.138

9.  Cone and rod cells have different target preferences in vitro as revealed by optical tweezers.

Authors:  Robert J Clarke; Kormákur Högnason; Michael Brimacombe; Ellen Townes-Anderson
Journal:  Mol Vis       Date:  2008-04-21       Impact factor: 2.367

Review 10.  Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy.

Authors:  Francesca Sciandra; Maria Giulia Bigotti; Bruno Giardina; Manuela Bozzi; Andrea Brancaccio
Journal:  Biomed Res Int       Date:  2015-08-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.